Norway has announced that you are at a greater risk of dying from AstraZeneca vaccine branded as Covishield in India than from COVID-19. While waiting for the final decision on the controversial vaccine, Norway has meanwhile decided to offload its stock of AstraZeneca to fellow Nordic countries that actually want to use them despite the associated risks.